DB

Deepika Bhatia

Active Director Director DIN 10961166
DIN 10961166 First appointment Feb 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2025
Shareholding value •••• Premium profile

About Deepika Bhatia

Data last updated:

Deepika Bhatia is a Director at Biocell Pharmaceuticals Private Limited (since 2025) and Director at Biocordis Pharmaceuticals Private Limited (since 2025). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹4.78 Cr; the largest is Biocell Pharmaceuticals Private Limited at ₹3.81 Cr (FY 2025).

DIN 10961166
Primary Designation Director
Industry Pharma
First Appointment 07 Feb 2025
Oldest Company Age 15 yrs
Largest company Biocell Pharmaceuticals Private Limited · ₹3.81 Cr (FY 2025)
Combined revenue ₹4.78 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Feb 20252011₹3.81 Cr (FY 2025)Active
Director07 Feb 20252011₹97.5 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Biocordis Pharmaceuticals Private Limited
Biocell Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Deepika Bhatia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepika Bhatia

Deepika Bhatia currently holds 2 directorships: Biocell Pharmaceuticals Private Limited (Director, since 07 Feb 2025, revenue ₹3.81 Cr (FY 2025)); Biocordis Pharmaceuticals Private Limited (Director, since 07 Feb 2025, revenue ₹97.5 Lakh (FY 2025)).

Deepika Bhatia was first appointed on 07 Feb 2025 as Director at Biocell Pharmaceuticals Private Limited.

The 2 current companies of Deepika Bhatia that report revenue have a combined latest revenue of ₹4.78 Cr: Biocell Pharmaceuticals Private Limited ₹3.81 Cr (FY 2025); Biocordis Pharmaceuticals Private Limited ₹97.5 Lakh (FY 2025).

The current boards of Deepika Bhatia's companies include Anurag Bhatia (Biocell Pharmaceuticals Private Limited), Karam Singh Babra (Biocordis Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available